Sphingosine kinase (SK) 1 is a host kinase that enhances some viral infections. Here we investigated the ability of SK1 to modulate dengue virus (DENV) infection in vitro. Overexpression of SK1 did not alter DENV infection; however, targeting SK1 through chemical inhibition resulted in reduced DENV RNA and infectious virus release. DENV infection of SK1− / − murine embryonic fibroblasts (MEFs) resulted in inhibition of infection in an immortalized line (iMEF) but enhanced infection in primary MEFs (1°MEFs). Global cellular gene expression profiles showed expected innate immune mRNA changes in DENV-infected WT but no induction of these responses in SK1− / − iMEFs. Reverse transciption PCR demonstrated a low-level induction of IFN-β and poor induction of mRNA for the interferon-stimulated genes (ISGs) viperin, IFIT1 and CXCL10 in DENV-infected SK1− / − compared with WT iMEFs. Similarly, reduced induction of ISGs was observed in SK1− / − 1°MEFs, even in the face of high-level DENV replication. In both iMEFs and 1°MEFs, DENV infection induced production of IFN-β protein. Additionally, higher basal levels of antiviral factors (IRF7, CXCL10 and OAS1) were observed in uninfected SK1− / − iMEFs but not 1°MEFs. This suggests that, in this single iMEF line, lack of SK1 upregulates the basal levels of factors that may protect cells against DENV infection. More importantly, regardless of the levels of DENV replication, all cells that lacked SK1 produced IFN-β but were refractory to induction of ISGs such as viperin, IFIT1 and CXCL10. Based on these findings, we propose new roles for SK1 in affecting innate responses that regulate susceptibility to DENV infection.
AdadaM. M., Orr-GandyK. A., SniderA. J., CanalsD., HannunY. A., ObeidL. M., ClarkeC. J.2013; Sphingosine kinase 1 regulates tumor necrosis factor-mediated RANTES induction through p38 mitogen-activated protein kinase but independently of nuclear factor κB activation. J Biol Chem 288:27667–27679 [View Article][PubMed]
AlvarezS. E., HarikumarK. B., HaitN. C., AllegoodJ., StrubG. M., KimE. Y., MaceykaM., JiangH., LuoC., other authors. 2010; Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465:1084–1088 [View Article][PubMed]
BlackwellJ. L., BrintonM. A.1997; Translation elongation factor-1 alpha interacts with the 3′ stem-loop region of West Nile virus genomic RNA. J Virol 71:6433–6444[PubMed]
CalvertJ. K., HelbigK. J., DimasiD., CockshellM., BeardM. R., PitsonS. M., BonderC. S., CarrJ. M.2015; Dengue virus infection of primary endothelial cells induces innate immune responses, changes in endothelial cells function and is restricted by interferon-stimulated responses. J Interferon Cytokine Res 35:654–665 [View Article][PubMed]
CarrJ. M., KuaT., ClarkeJ. N., CalvertJ. K., ZebolJ. R., BeardM. R., PitsonS. M.2013a; Reduced sphingosine kinase 1 activity in dengue virus type-2 infected cells can be mediated by the 3′ untranslated region of dengue virus type-2 RNA. J Gen Virol 94:2437–2448 [View Article][PubMed]
ChenH. W., KingK., TuJ., SanchezM., LusterA. D., ShrestaS.2013; The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. J Immunol 191:4194–4201 [View Article][PubMed]
DavisW. G., BlackwellJ. L., ShiP. Y., BrintonM. A.2007; Interaction between the cellular protein eEF1A and the 3′-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J Virol 81:10172–10187 [View Article][PubMed]
GualanoR. C., PryorM. J., CauchiM. R., WrightP. J., DavidsonA. D.1998; Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. J Gen Virol 79:437–446 [View Article][PubMed]
HarikumarK. B., YesterJ. W., SuraceM. J., OyeniranC., PriceM. M., HuangW. C., HaitN. C., AllegoodJ. C., YamadaA., other authors. 2014; K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol 15:231–238 [View Article][PubMed]
HelbigK. J., CarrJ. M., CalvertJ. K., WatiS., ClarkeJ. N., EyreN. S., NarayanaS. K., FichesG. N., McCartneyE. M., BeardM. R.2013; Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis 7:e2178 [View Article][PubMed]
JiangD., WeidnerJ. M., QingM., PanX. B., GuoH., XuC., ZhangX., BirkA., ChangJ., other authors. 2010; Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 84:8332–8341 [View Article][PubMed]
LeclercqT. M., MorettiP. A., VadasM. A., PitsonS. M.2008; Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity. J Biol Chem 283:9606–9614 [View Article][PubMed]
LeclercqT. M., MorettiP. A., PitsonS. M.2011; Guanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesis. Oncogene 30:372–378 [View Article][PubMed]
LiewK. J., ChowV. T.2006; Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J Virol Methods 131:47–57 [View Article][PubMed]
MaceykaM., MilstienS., SpiegelS.2009; Sphingosine-1-phosphate: the Swiss army knife of sphingolipid signaling. J Lipid Res 50:S272–S276 [View Article][PubMed]
MarsolaisD., HahmB., WalshK. B., EdelmannK. H., McGavernD., HattaY., KawaokaY., RosenH., OldstoneM. B.2009; A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A 106:1560–1565 [View Article][PubMed]
OldstoneM. B., RosenH.2014; Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. Curr Top Microbiol Immunol 378:129–147[PubMed]
OskeritzianC. A., AlvarezS. E., HaitN. C., PriceM. M., MilstienS., SpiegelS.2008; Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood 111:4193–4200 [View Article][PubMed]
PaughS. W., PaughB. S., RahmaniM., KapitonovD., AlmenaraJ. A., KordulaT., MilstienS., AdamsJ. K., ZipkinR. E., other authors. 2008; A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 112:1382–1391 [View Article][PubMed]
PchejetskiD., NunesJ., CoughlanK., LallH., PitsonS. M., WaxmanJ., SumbayevV. V.2011; The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1α protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6. Immunol Cell Biol 89:268–274 [View Article][PubMed]
PerelyginA. A., ScherbikS. V., ZhulinI. B., StockmanB. M., LiY., BrintonM. A.2002; Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci U S A 99:9322–9327 [View Article][PubMed]
PhamD. H., PowellJ. A., GliddonB. L., MorettiP. A., TsykinA., Van der HoekM., KenyonR., GoodallG. J., PitsonS. M.2014; Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1. Oncogene 33:5559–5568 [View Article][PubMed]
PitsonS. M., MorettiP. A., ZebolJ. R., XiaP., GambleJ. R., VadasM. A., D'AndreaR. J., WattenbergB. W.2000; Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J Biol Chem 275:33945–33950 [View Article][PubMed]
PitsonS. M., MorettiP. A., ZebolJ. R., LynnH. E., XiaP., VadasM. A., WattenbergB. W.2003; Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 22:5491–5500 [View Article][PubMed]
PitsonS. M., XiaP., LeclercqT. M., MorettiP. A., ZebolJ. R., LynnH. E., WattenbergB. W., VadasM. A.2005; Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J Exp Med 201:49–54 [View Article][PubMed]
PyneS., BittmanR., PyneN. J.2011; Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res 71:6576–6582 [View Article][PubMed]
RosenH., Germana SannaM., Gonzalez-CabreraP. J., RobertsE.2014; The organization of the sphingosine 1-phosphate signaling system. Curr Top Microbiol Immunol 378:1–21[PubMed]
SeoY. J., AlexanderS., HahmB.2011; Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections?. Cytokine Growth Factor Rev 22:55–61 [View Article][PubMed]
SeoY. J., PritzlC. J., VijayanM., BombK., McClainM. E., AlexanderS., HahmB.2013; Sphingosine kinase 1 serves as a pro-viral factor by regulating viral RNA synthesis and nuclear export of viral ribonucleoprotein complex upon influenza virus infection. PLoS One 8:e75005 [View Article][PubMed]
WalshK. B., TeijaroJ. R., WilkerP. R., JatzekA., FremgenD. M., DasS. C., WatanabeT., HattaM., ShinyaK., other authors. 2011; Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 108:12018–12023 [View Article][PubMed]
WalshK. B., TeijaroJ. R., BrockL. G., FremgenD. M., CollinsP. L., RosenH., OldstoneM. B.2014; Animal model of respiratory syncytial virus: CD8+T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy. J Virol 88:6281–6293 [View Article][PubMed]
WatiS., RawlinsonS. M., IvanovR. A., DorstynL., BeardM. R., JansD. A., PitsonS. M., BurrellC. J., LiP., CarrJ. M.2011; Tumour necrosis factor alpha (TNF-α) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-α to activate nuclear factor κB and reduced sphingosine kinase-1 activity. J Gen Virol 92:807–818 [View Article][PubMed]
YamaneD., ZahoorM. A., MohamedY. M., AzabW., KatoK., TohyaY., AkashiH.2009; Inhibition of sphingosine kinase by bovine viral diarrhea virus NS3 is crucial for efficient viral replication and cytopathogenesis. J Biol Chem 284:13648–13659 [View Article][PubMed]
YamaneD., McGivernD. R., WauthierE., YiM., MaddenV. J., WelschC., AntesI., WenY., ChughP. E., other authors. 2014; Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med 20:927–935 [View Article][PubMed]
YangC. H., MurtiA., PfefferS. R., FanM., DuZ., PfefferL. M.2008; The role of TRAF2 binding to the type I interferon receptor in alternative NFκB activation and antiviral response. J Biol Chem 283:14309–14316 [View Article][PubMed]